Infrared light therapy relieves TLR-4 dependent hyper-inflammation of the type induced by COVID-19

References

• Mortaz E, Tabarsi P, Varahram M, et al. The immune response and immunopathology of COVID-19. Front Immunol. 2020;11. DOI:https://doi.org/10.3389/fimmu.2020.02037
   PubMedGoogle Scholar
• Hu B, Guo H, Zhou P, et al. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141–154.
   PubMed Web of Science ®Google Scholar
• Ragab D, Salah Eldin H, Taeimah M, et al. The COVID-19 cytokine storm; what we know so far. Front Immunol. 2020;11. DOI:https://doi.org/10.3389/fimmu.2020.01446
   Web of Science ®Google Scholar
• Mishra KP, Singh AK, Singh SB. Hyperinflammation and Immune Response Generation in COVID-19. NIM. 2020;27:80–86.
   Google Scholar
• Chowdhury MA, Hossain N, Kashem MA, et al. Immune response in COVID-19: a review. J Infect Public Health. 2020;13(11):1619–1629.
   PubMed Web of Science ®Google Scholar
• Olejnik J, Hume AJ, Mühlberger E. Toll-like receptor 4 in acute viral infection: too much of a good thing. PLoS Pathog. 2018;14(12):e1007390.
   PubMed Web of Science ®Google Scholar
• Park BS, Lee J-O. Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp Mol Med. 2013;45(12):e66.
   PubMedGoogle Scholar
• Park S, Shin H-J, Shah M, et al. TLR4/MD2 specific peptides stalled in vivo LPS-induced immune exacerbation. Biomaterials. 2017;126:49–60.
   PubMed Web of Science ®Google Scholar
• Imai Y, Kuba K, Neely GG, et al. Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133(2):235–249.
   PubMed Web of Science ®Google Scholar
• Sohn KM, Lee S-G, Kim HJ, et al. COVID-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial sepsis. J Korean Med Sci. 2020;35(38):e343.
   Web of Science ®Google Scholar
• Bhattacharya M, Sharma AR, Mallick B, et al. Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex. Infect Genet Evol. 2020;85:104587.
   PubMed Web of Science ®Google Scholar
• choudhury and mukherjee. In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE-2 receptor homologs and human TLRs - Choudhury - 2020. J Med Virol. Wiley Online Library. 2020;92(10):2105–2113.
   Web of Science ®Google Scholar
• Zhao Y, Kuang M, Li J, et al. SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Res. 2021;31(7):818–820.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Kuang M, Li J, et al. Publisher correction: SARS-CoV-2 spike protein interacts with and activates TLR4. Cell Res. 2021;31(7):825.
   PubMed Web of Science ®Google Scholar
• Shirato K, Kizaki T. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages. Heliyon. 2021;7(2):e06187.
   PubMed Web of Science ®Google Scholar
• Sender V, Stamme C. Lung cell-specific modulation of LPS-induced TLR4 receptor and adaptor localization. Commun Integr Biol. 2014;7(4):e29053.
   PubMedGoogle Scholar
• Xu X, Han M, Li T, et al. Effective treatment of severe COVID-19 patients with tocilizumab. PNAS. 2020;117(20):10970–10975.
   PubMed Web of Science ®Google Scholar
• Della-Torre E, Lanzillotta M, Campochiaro C, et al. Respiratory impairment predicts response to IL-1 and IL-6 blockade in COVID-19 patients with severe pneumonia and hyper-inflammation. Front Immunol. 2021;12. DOI:https://doi.org/10.3389/fimmu.2021.675678
   Google Scholar
• Gordon. Interleukin-6 receptor antagonists in critically Ill patients with Covid-19. N Engl J Med. 2021;384(16):1491–1502.
   PubMed Web of Science ®Google Scholar
• Fekrazad R. Photobiomodulation and antiviral photodynamic therapy as a possible novel approach in COVID-19 management. Photobiomodul Photomed Laser Surg. 2020;38(5):255–257.
   PubMed Web of Science ®Google Scholar
• Nejatifard M, Asefi S, Jamali R, et al. Probable positive effects of the photobiomodulation as an adjunctive treatment in COVID-19: a systematic review. Cytokine. 2021;137:155312.
   PubMed Web of Science ®Google Scholar
• Bjordal JM, R A L-M, Iversen B. A randomised, placebo controlled trial of low level laser therapy for activated Achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrations. Br J Sports Med. 2006;40(1):76–80. discussion 76-80.
   PubMed Web of Science ®Google Scholar
• Avci P, Gupta GK, Clark J, et al. Low-level laser (light) therapy (LLLT) for treatment of hair loss. Lasers Surg Med. 2014;46(2):144–151.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Foley KA. A critical assessment of the evidence for low-level laser therapy in the treatment of hair loss. Dermatol Surg. 2017;43(2):188–197.
   PubMed Web of Science ®Google Scholar
• Ablon G. Combination 830-nm and 633-nm light-emitting diode phototherapy shows promise in the treatment of recalcitrant psoriasis: preliminary findings. Photomed Laser Surg. 2010;28(1):141–146.
   PubMed Web of Science ®Google Scholar
• Choi M, Na SY, Cho S, et al. Low level light could work on skin inflammatory disease: a case report on refractory acrodermatitis continua. J Korean Med Sci. 2011;26(3):454–456.
   PubMed Web of Science ®Google Scholar
• Höfling DB, Chavantes MC, Acencio MMP. Effects of low-level laser therapy on the serum TGF-β1 concentrations in individuals with autoimmune thyroiditis. Photomed Laser Surg. 2014;32(8):444–449.
   PubMed Web of Science ®Google Scholar
• Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 2017;4(3):337–361.
   PubMed Web of Science ®Google Scholar
• Ip D. Does addition of low-level laser therapy (LLLT) in conservative care of knee arthritis successfully postpone the need for joint replacement? Lasers Med Sci. 2015;30(9):2335–2339.
   PubMed Web of Science ®Google Scholar
• Carvalho JLC, de Brito AA, de Oliveira APL. The chemokines secretion and the oxidative stress are targets of low-level laser therapy in allergic lung inflammation. J Biophotonics. 2016;9(11–12):1208–1221.
   PubMed Web of Science ®Google Scholar
• Silva VR, Marcondes P, Silva M, et al. Low-level laser therapy inhibits bronchoconstriction, Th2 inflammation and airway remodeling in allergic asthma. Respir Physiol Neurobiol. 2014;194:37–48.
   PubMed Web of Science ®Google Scholar
• De Lima FM, Villaverde AB, Albertini R. Dual Effect of low-level laser therapy (LLLT) on the acute lung inflammation induced by intestinal ischemia and reperfusion: action on anti- and pro-inflammatory cytokines. Lasers Surg Med. 2011;43(5):410–420.
   PubMed Web of Science ®Google Scholar
• De Lima FM, Albertini R, Dantas Y. Low-Level laser therapy restores the oxidative stress balance in acute lung injury induced by gut ischemia and reperfusion. Photochem Photobiol. 2013;89(1):179–188.
   PubMed Web of Science ®Google Scholar
• Da Silva JGF, dos Santos SS, de Almeida P, et al. Effect of systemic photobiomodulation in the course of acute lung injury in rats. Lasers Med Sci. 2021;36(5):965–973.
   PubMed Web of Science ®Google Scholar
• Rajendran N, Kumar N, George BP, et al. the influence of light on reactive oxygen species and NF-кB in disease progression. Antioxidants. 2019;8(12):640.
   Web of Science ®Google Scholar
• Pooam M, Aguida B, Drahy S, et al. Therapeutic application of light and electromagnetic fields to reduce hyper-inflammation triggered by COVID-19. Commun Integr Biol. 2021;14(1):66–77.
   PubMedGoogle Scholar
• Sigman SA, Mokmeli S, Monici M, et al. A 57-Year-old African American man with severe covid-19 pneumonia who responded to supportive Photobiomodulation Therapy (PBMT): first use of PBMT in COVID-19. Am J Case Rep. 2020;21:e926779-1-e926779-7.
   PubMed Web of Science ®Google Scholar
• Sigman SA, Mokmeli S, Vetrici MA. Adjunct low level laser therapy (LLLT) in a morbidly obese patient with severe COVID-19 pneumonia: a case report. Can J Respir Ther. 2020;56:52–56.
   PubMedGoogle Scholar
• Vetrici MA, Mokmeli S, Bohm AR, et al. Evaluation of adjunctive photobiomodulation (PBMT) for COVID-19 pneumonia via clinical status and pulmonary severity indices in a preliminary trial. JIR. 2021;14:965–979.
   Google Scholar
• Lecca D, Nevin DK, Mulas G, et al. Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice. Neuroscience. 2015;302:23–35.
   PubMed Web of Science ®Google Scholar
• Rahiman SSF, Morgan M, Gray P, et al. Inhibitory effects of dynorphin 3-14 on the lipopolysaccharide-induced toll-like receptor 4 signalling pathway. Peptides. 2017;90:48–54.
   PubMed Web of Science ®Google Scholar
• Chu M, Zhou M, Jiang C, et al. Staphylococcus aureus phenol-soluble modulins α1–α3 act as novel toll-like receptor (TLR) 4 antagonists to inhibit HMGB1/TLR4/NF-κB signaling pathway. Front Immunol. 2018;9:862.
   PubMed Web of Science ®Google Scholar
• Mortazavi-Jahromi SS, Farazmand A, Motamed N, et al. Effects of guluronic acid (G2013) on SHIP1, SOCS1 induction and related molecules in TLR4 signaling pathway. Int Immunopharmacol. 2018;55:323–329.
   PubMed Web of Science ®Google Scholar
• Oyler BL, Khan MM, Smith DF, et al. top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate. J Am Soc Mass Spectrom. 2018;29(6):1221–1229.
   PubMed Web of Science ®Google Scholar
• Peng Y, Bishop KS, Ferguson LR, et al. Screening of cytotoxicity and anti-inflammatory properties of feijoa extracts using genetically modified cell models targeting TLR2, TLR4 and NOD2 pathways, and the implication for inflammatory bowel disease. Nutrients. 2018;10(9):1188.
   Web of Science ®Google Scholar
• Xie N, Matigian N, Vithanage T, et al. Effect of perioperative opioids on cancer-relevant circulating parameters: mu opioid receptor and toll-like receptor 4 activation potential, and proteolytic profile. Clin Cancer Res. 2018;24(10):2319–2327.
   PubMed Web of Science ®Google Scholar
• Xu Y, Chen S, Cao Y, et al. Discovery of novel small molecule TLR4 inhibitors as potent anti-inflammatory agents. Eur J Med Chem. 2018;154:253–266.
   PubMed Web of Science ®Google Scholar
• Moretti S, Smets W, Hofman J, et al. Human inflammatory response of endotoxin affected by particulate matter-bound transition metals. Environ Pollut. 2019;244:118–126.
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang Y, Lin X, et al. Specific TLR4 blocking effect of a novel 3,4-dihydropyrimidinone derivative. Front Pharmacol. 2021;11.
   Web of Science ®Google Scholar
• Shuai H, Chu H, Hou Y, et al. Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: implications for treatment with IFN-β and IFN inducer. J Infect. 2020;81(4):e1–e10.
   PubMed Web of Science ®Google Scholar
• Aboudounya MM, Heads RJ, Dozio E. COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation. Mediators Inflamm. 2021;2021:e8874339.
   PubMed Web of Science ®Google Scholar
• Johnston A, Xing X, Wolterink L, et al. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J Allergy Clin Immunol. 2017;140(1):109–120.
   PubMed Web of Science ®Google Scholar
• Mittal M, Siddiqui MR, Tran K, et al. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 2014;20(7):1126–1167.
   PubMed Web of Science ®Google Scholar
• West AP, Brodsky IE, Rahner C, et al. TLR signaling augments macrophage bactericidal activity through mitochondrial ROS. Nature. 2011;472(7344):476–480.
   PubMed Web of Science ®Google Scholar